Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction
Yuejie Chen(Tsinghua University), Feng Qian(Guangxi University), Michael J. Hageman(Bristol-Myers Squibb (United States)), Munir Hussain(Zhejiang Sci-Tech University), Shan Wang(Xianyang Normal University), Shujing Wang(Anhui Medical University), Roy Haskell(Bristol-Myers Squibb (United States)), Kevin Stefanski(Bristol-Myers Squibb (United States)), Ching Su(Bristol-Myers Squibb (United States))
Cited by 114
Related Papers
Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance
|npj Precision Oncology|2024|535
Improving Oral Bioavailability of Sorafenib by Optimizing the “Spring” and “Parachute” Based on Molecular Interaction Mechanisms
|Molecular Pharmaceutics|2015|165
Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion
|Molecular Pharmaceutics|2016|73
Oxymatrine attenuated hypoxic-ischemic brain damage in neonatal rats via improving antioxidant enzyme activities and inhibiting cell death
|Neurochemistry International|2015|66
Development of colloidal gold-based immunochromatographic assay for rapid detection of Mycoplasma suis in porcine plasma
|Biosensors and Bioelectronics|2014|65